WOLVERINE ASSET MANAGEMENT LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 52 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 18.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2017$15,000
+150.0%
6,7150.0%0.00%
Q4 2016$6,000
-14.3%
6,7150.0%0.00%
Q3 2016$7,000
-22.2%
6,7150.0%0.00%
Q2 2016$9,0000.0%6,7150.0%0.00%
Q1 2016$9,000
-18.2%
6,7150.0%0.00%
Q4 2015$11,000
-26.7%
6,7150.0%0.00%
Q3 2015$15,000
-16.7%
6,7150.0%0.00%
Q2 2015$18,000
-96.0%
6,715
-87.9%
0.00%
-100.0%
Q4 2013$447,00055,4390.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders